TRANSFORMING GROWTH FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR IN PROTECTION AND HEALING OF GASTRIC-MUCOSAL INJURY

被引:147
作者
KONTUREK, SJ [1 ]
BRZOZOWSKI, T [1 ]
MAJKA, J [1 ]
DEMBINSKI, A [1 ]
SLOMIANY, A [1 ]
SLOMIANY, BL [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,RES CTR,NEWARK,NJ 07103
关键词
CYTOPROTECTION; ETHANOL; GROWTH FACTOR; PROSTAGLANDINS; STRESS;
D O I
10.3109/00365529209000134
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Transforming growth factor alpha (TGF) and epidermal growth factor (EGF) present in the gastric mucosa are polypeptides with similar biologic activity. This study compares the activity of TGF and EGF in the protection against injury by 100% ethanol and stress and in healing of acute gastric ulcerations. TGF and EGF (12.5-100-mu-g/kg-h) infused subcutaneously 30 min before and during ethanol or stress decreased mucosal lesions dose-dependently. The ID50 for ethanol- and stress-induced lesions after TGF were 40 and 70-mu-g/kg-h and after EGF 60 and 100-mu-g/kg-h. TGF and EGF infused subcutaneously into intact rats inhibited gastric acid secretion but did not affect the gastric blood flow or mucosal generation of prostaglandin E2 (PGE2). Both TGF and EGF also significantly enhanced the healing of stress-induced lesions and the restoration of DNA synthesis. Ethanol and stress reduced blood flow in the oxyntic mucosa by 68% and 51%, respectively, and this effect was partially reversed by EGF and TGF. Pretreatment with indomethacin (5 mg/kg intraperitoneally), which reduced mucosal generation of PGE2 by 85%, decreased in part the protection by TGF and EGF against ethanol-induced damage and virtually abolished the protective action of these peptides against stress-induced injury. We conclude therefore that 1) TGF and EGF show similar and comparable gastroprotective activity against ethanol- and stress-induced damage; 2) the protection by TGF and EGF is accompanied by an increase in gastric blood flow which appears to be an essential factor in gastroprotection; 3) mucosal PG is necessary for manifestation of the protective activity of TGF and EGF against acute gastric damage; and 4) TGF and EGF enhance the healing of gastric lesions, possibly via stimulation of DNA synthesis and cell proliferation.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 21 条
  • [1] AHU H, 1988, SCAND J GASTROENTERO, V23, P1203
  • [2] LOCALIZATION OF TRANSFORMING GROWTH FACTOR-ALPHA AND ITS RECEPTOR IN GASTRIC-MUCOSAL CELLS - IMPLICATIONS FOR A REGULATORY ROLE IN ACID-SECRETION AND MUCOSAL RENEWAL
    BEAUCHAMP, RD
    BARNARD, JA
    MCCUTCHEN, CM
    CHERNER, JA
    COFFEY, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) : 1017 - 1023
  • [3] TRANSFORMING GROWTH FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR LEVELS IN NORMAL HUMAN GASTROINTESTINAL MUCOSA
    CARTLIDGE, SA
    ELDER, JB
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (05) : 657 - 660
  • [4] EFFECT OF SUCRALFATE ON GASTRIC-MUCOSAL BLOOD-FLOW IN RATS
    CHEN, BW
    HIU, WM
    LAM, SK
    CHO, CH
    NG, MMT
    LUK, CT
    [J]. GUT, 1989, 30 (11) : 1544 - 1551
  • [5] TROPHIC ACTION OF EPIDERMAL GROWTH-FACTOR ON THE PANCREAS AND GASTRODUODENAL MUCOSA IN RATS
    DEMBINSKI, A
    GREGORY, H
    KONTUREK, SJ
    POLANSKI, M
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1982, 325 (APR): : 35 - 42
  • [6] TRANSFORMING GROWTH FACTOR-ALPHA - STRUCTURE AND BIOLOGICAL-ACTIVITIES
    DERYNCK, R
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, 32 (04) : 293 - 304
  • [7] ISOLATION AND STRUCTURE OF UROGASTRONE AND ITS RELATIONSHIP TO EPIDERMAL GROWTH-FACTOR
    GREGORY, H
    [J]. NATURE, 1975, 257 (5524) : 325 - 327
  • [8] ROLE OF EPIDERMAL GROWTH-FACTOR, PROSTAGLANDIN, AND SULFHYDRYLS IN STRESS-INDUCED GASTRIC-LESIONS
    KONTUREK, PK
    BRZOZOWSKI, T
    KONTUREK, SJ
    DEMBINSKI, A
    [J]. GASTROENTEROLOGY, 1990, 99 (06) : 1607 - 1615
  • [9] ROLE OF EPIDERMAL GROWTH-FACTOR IN HEALING OF CHRONIC GASTRODUODENAL ULCERS IN RATS
    KONTUREK, SJ
    DEMBINSKI, A
    WARZECHA, Z
    BRZOZOWSKI, T
    GREGORY, H
    [J]. GASTROENTEROLOGY, 1988, 94 (06) : 1300 - 1307
  • [10] KONTUREK SJ, 1990, GASTROENTEROL CLIN N, V19, P41